Study ID: ALS-TAL-201 (ALSTAR) | ALSTAR
Study Title
- Talampanel for Amyotrophic Lateral Sclerosis (ALS)
Teva Identifier
- ALS-TAL-201 (ALSTAR) | ALSTAR
ClinicalTrials.gov Identifier
- NCT00696332
Study Status
- Completed
Trial Condition(s)
- ALS
Interventions
- Drug: Talampanel | Other: placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 80 Years
Trial Duration
- 09/01/2008 - 05/01/2010
Phase
- Phase 2
Study Type
Interventional